Client & Alumni News
Particle Sciences, Bethlehem, a leading drug delivery CRO, has developed a novel ocular formulation for its client, Eyeon Therapeutics, Inc. The formulation, based on a polymer owned by Particle Sciences, provides superior clinical results in treating dry eye. The results were published earlier this year in the Journal of Ocular Pharmacology and Therapeutic.
Read more here: http://www.sacbee.com/2012/11/07/4967908/particle-sciences-develops-novel.html#storylink=cpy
